| 000 | 00960 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518003419.0 | ||
| 264 | 0 | _c20181023 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc1809736 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBhattacharyya, Shamik | |
| 245 | 0 | 0 |
_aCardiovascular Safety of Febuxostat. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _c10 2018 |
||
| 300 |
_a1582 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aCardiovascular System |
| 650 | 0 | 4 | _aFebuxostat |
| 650 | 0 | 4 | _aGout |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aThiazoles |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUric Acid |
| 700 | 1 | _aMacklin, Eric A | |
| 700 | 1 | _aSchwarzschild, Michael A | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 379 _gno. 16 _gp. 1582 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1809736 _zAvailable from publisher's website |
| 999 |
_c28956585 _d28956585 |
||